-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$9.0011.8% Upside
CorMedix Inc. Frequently Asked Questions
-
What analysts cover CorMedix Inc.?
CorMedix Inc. has been rated by research analysts at RBC Capital in the past 90 days.